| Name | 1Alphah,5alphah-tropan-3alpha-ol (+-)-tripate (ester), hydrobromide |
|---|
| Description | Atropine (Tropine tropate) hydrobromide is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine hydrobromide inhibits ACh-induced relaxations in human pulmonary veins. Atropine hydrobromide can be used for research of anti-myopia and bradycardia[1][2][3][4]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.39 nM (Human mAChR M4) and 0.71 nM (Chicken mAChR M4)[3] |
| In Vitro | Atropine (Tropine tropate; 1 μM; pulmonary veins and arteries) hydrobromide inhibits ACh-induced relaxations in human pulmonary veins[4]. |
| In Vivo | Atropine (Tropine tropate; 10 mg/kg; i.p.; once, for 40 minutes; Peromyscus sp.) hydrobromide inhibits the cardiac arrhythmia which normally occurs throughout torpor[2]. Animal Model: White-footed mice (Peromyscus sp.)[2] Dosage: 10 mg/kg Administration: Intraperitoneal injection; once, for 40 minutes Result: Increased heart rate was a decrease in cardiac arrhythmia. |
| References |
| Molecular Formula | C17H24BrNO3 |
|---|---|
| Molecular Weight | 370.28100 |
| Exact Mass | 369.09400 |
| PSA | 49.77000 |
| LogP | 2.82690 |
| Precursor 0 | |
|---|---|
| DownStream 1 | |